These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30738604)

  • 1. Adjuvant and neoadjuvant cancer therapies: A historical review and a rational approach to understand outcomes.
    Burotto M; Wilkerson J; Stein WD; Bates SE; Fojo T
    Semin Oncol; 2019 Feb; 46(1):83-99. PubMed ID: 30738604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer: the potential and the questions.
    Goble S; Bear HD
    Surg Clin North Am; 2003 Aug; 83(4):943-71. PubMed ID: 12875604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant chemotherapy for bladder cancer.
    Black PC; Brown GA; Grossman HB; Dinney CP
    World J Urol; 2006 Nov; 24(5):531-42. PubMed ID: 17115230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant chemotherapy for gastric adenocarcinoma in Japan.
    Kodera Y
    Surg Today; 2017 Aug; 47(8):899-907. PubMed ID: 28247105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant Therapy for HER2-positive Breast Cancer.
    Wuerstlein R; Harbeck N
    Rev Recent Clin Trials; 2017; 12(2):81-92. PubMed ID: 28164759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
    Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant therapy for melanoma: a promising therapeutic approach and an ideal platform in drug development.
    Tarhini AA
    Am Soc Clin Oncol Educ Book; 2015; ():e535-42. PubMed ID: 25993220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant therapy for pancreas cancer: past lessons and future therapies.
    Sutton JM; Abbott DE
    World J Gastroenterol; 2014 Nov; 20(42):15564-79. PubMed ID: 25400440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemotherapy for early breast cancer: practices in 2010].
    Frénel JS; Campone M
    J Gynecol Obstet Biol Reprod (Paris); 2010 Dec; 39(8 Suppl):F79-84. PubMed ID: 21115288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant and neoadjuvant therapies in resectable pancreatic cancer: a systematic review of randomized controlled trials.
    D'Angelo FA; Antolino L; La Rocca M; Petrucciani N; Magistri P; Aurello P; Ramacciato G
    Med Oncol; 2016 Mar; 33(3):28. PubMed ID: 26883935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Updates on the use of neoadjuvant therapy in borderline resectable pancreatic cancer.
    Chandhok NS; Saif MW
    JOP; 2014 Mar; 15(2):91-4. PubMed ID: 24618425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimetastatic intraoperative chemotherapy of human colon tumors in the livers of nude mice.
    Rashidi B; An Z; Sun FX; Moossa AR; Hoffman RM
    Clin Cancer Res; 2000 Jun; 6(6):2464-8. PubMed ID: 10873100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translating neoadjuvant therapy into survival benefits: one size does not fit all.
    De Mattos-Arruda L; Shen R; Reis-Filho JS; Cortés J
    Nat Rev Clin Oncol; 2016 Sep; 13(9):566-79. PubMed ID: 27000962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National Trends in the Use of Neoadjuvant Chemotherapy for Hormone Receptor-Negative Breast Cancer: A National Cancer Data Base Study.
    Puig CA; Hoskin TL; Day CN; Habermann EB; Boughey JC
    Ann Surg Oncol; 2017 May; 24(5):1242-1250. PubMed ID: 28000076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current and future roles of neoadjuvant chemotherapy in operable breast cancer.
    Kim R; Osaki A; Toge T
    Clin Breast Cancer; 2005 Aug; 6(3):223-32; discussion 233-4. PubMed ID: 16137432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in Neoadjuvant Approaches in Pancreatic Cancer.
    Du L; Wang-Gillam A
    J Natl Compr Canc Netw; 2017 Aug; 15(8):1070-1077. PubMed ID: 28784867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Future endocrine therapy of breast cancer].
    Ejlertsen B
    Ugeskr Laeger; 2007 Jan; 169(4):296. PubMed ID: 17274921
    [No Abstract]   [Full Text] [Related]  

  • 19. Neoadjuvant therapy for gastric cancer.
    Chadha MK; Kuvshinoff BW; Javle MM
    Oncology (Williston Park); 2005 Aug; 19(9):1219-27; discussion 1227-8, 1231-2. PubMed ID: 16255136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant or Neoadjuvant Therapy in the Treatment in Pancreatic Malignancies: Where Are We?
    Wolff RA
    Surg Clin North Am; 2018 Feb; 98(1):95-111. PubMed ID: 29191281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.